Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients

被引：10
作者：
Eroglu, Aydan [1 ]
Akar, Nejat [2 ]
机构：
[1] Ankara Univ, Sch Med, Dept Gen Surg, TR-06590 Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Pediat Genet, TR-06590 Ankara, Turkey
来源：
THROMBOSIS RESEARCH | 2011年 / 127卷 / 04期
关键词：
VENOUS THROMBOEMBOLISM; METAANALYSIS; THROMBOSIS; MUTATIONS;
D O I：
10.1016/j.thromres.2010.10.025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：384 / 385
页数：2
相关论文
共 12 条
[1]   Effect of Factor v Leiden and prothrombin G20210→A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial [J].
Abramson, Neil ;
Costantino, Joseph R. ;
Garber, Judy E. ;
Berliner, Nancy ;
Wickerham, D. Lawrence ;
Wolmark, Norman .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (13) :904-910
[2]   Dihydrofolate reductase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer [J].
Cam, Ragip ;
Eroglu, Aydan ;
Egin, Yonca ;
Akar, Nejat .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 115 (02) :431-432
[3]   Tamoxifen and the Factor V Leiden Mutation [J].
Cuzick, Jack .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (13) :918-U1
[4]   The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma - A systematic review [J].
Deitcher, SR ;
Gomes, MPV .
CANCER, 2004, 101 (03) :439-449
[5]  
Dentali F, 2008, J THROMB HAEMOST, V6, P70
[6]  
Eroglu A, 2008, J BUON, V13, P61
[7]   PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer [J].
Eroglu, A ;
Çam, R ;
Yildiz, Z ;
Akar, N .
THROMBOSIS RESEARCH, 2003, 111 (4-5) :317-319
[8]   Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer [J].
Eroglu, Aydan ;
Cam, Ragip ;
Egin, Yonca ;
Akar, Nejat .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (03) :619-620
[9]   Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer [J].
Garber, Judy E. ;
Halabi, Susan ;
Tolaney, Sara M. ;
Kaplan, Ellen ;
Archer, Laura ;
Atkins, James N. ;
Edge, Stephen ;
Shapiro, Charles L. ;
Dressler, Lynn ;
Paskett, Electra M. ;
Kimmick, Gretchen ;
Orcutt, James ;
Scalzo, Anthony ;
Winer, Eric ;
Levine, Ellis ;
Shahab, Nasir ;
Berliner, Nancy .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (13) :942-949
[10]   Venous thromboembolism and cancer: Risks and outcomes [J].
Lee, AYY ;
Levine, MN .
CIRCULATION, 2003, 107 :I17-I21
12